NasdaqCM:BLFSLife Sciences
Why BioLife Solutions (BLFS) Is Up 13.4% After Q1 Return To Profitability And Reaffirmed Outlook
In the first quarter of 2026, BioLife Solutions, Inc. reported sales of US$27.5 million, up from US$22.05 million a year earlier, and moved from a net loss of US$448,000 to net income of US$1.19 million, with basic and diluted earnings per share of US$0.02.
The company also reiterated its 2026 revenue outlook of US$112.5 million to US$115.0 million and an expectation of full-year GAAP net income, underscoring management’s confidence in ongoing demand for its cell and gene therapy support...